IDEX Corporation's (IEX) third-quarter 2024 adjusted earnings of $1.90 per share surpassed the Zacks Consensus Estimate of $1.89. The bottom line decreased approximately 10.4% from the year-ago quarter's earnings of $2.12. However, it matched the upper band of the management's projected range of $1.85-$1.90 per share. Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar. IEX's Revenue Details IDEX's net sales of $798.2 million beat the Zacks Consensus Estimate of $791 million. The top li ...

For the quarter ended September 2024, Idex (IEX) reported revenue of $798.2 million, up 0.6% over the same period last year. EPS came in at $1.90, compared to $2.12 in the year-ago quarter. The reported revenue represents a surprise of +0.92% over the Zacks Consensus Estimate of $790.95 million. With the consensus EPS estimate being $1.89, the EPS surprise was +0.53%. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expec ...

Idex (IEX) came out with quarterly earnings of $1.90 per share, beating the Zacks Consensus Estimate of $1.89 per share. This compares to earnings of $2.12 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 0.53%. A quarter ago, it was expected that this maker of the Jaws of Life device and other engineered products would post earnings of $2.04 per share when it actually produced earnings of $2.06, delivering a surprise of 0.98% ...

文章核心观点 - IDEX Biometrics任命Kristian Flaten为首席财务官,他拥有25年的国际业务和融资经验,尤其在亚洲增长市场方面有丰富经验,这对IDEX Biometrics的发展非常重要[1][2][3] - Kristian Flaten在企业财务、债务融资和增长型公司业务发展方面有出色的业绩记录[2][3] - Kristian Flaten的加入是IDEX Biometrics业务转型的重要一步,他的经验将有助于公司战略举措的推进和生物识别平台及软件解决方案在关键市场的创新发展[3] 公司概况 - IDEX Biometrics是一家指纹生物识别技术的全球领导者,为支付、访问控制和数字身份认证提供认证解决方案[4] - 公司的生物识别解决方案基于专利和专有的传感器技术、集成电路设计和软件,主要针对基于卡的支付和数字认证应用[4] - 作为行业推动者,公司与领先的卡制造商和技术公司合作,将其解决方案推向市场[4] 人事变动 - Kristian Flaten接替John Kurtzweil担任IDEX Biometrics的首席财务官[3] - John Kurtzweil将继续以顾问的身份为公司提供支持,公司对他在任期内的出色贡献和确保Kristian顺利过渡表示衷心感谢[3]

Oslo, Norway – 29 October 2024 - IDEX Biometrics ASA’s interim report for the third quarter is attached to this notice (link below). The interim report is also available on the IDEX Biometrics website: www.idexbiometrics.com/investors/interim-results/ A webcast presentation of the interim report will be held by Catharina Eklof, Chief Executive Officer, today at 09:00 CET. The webcast presentation is attached to this notice (link below), and can be viewed at the following link: https://idexbiometrics.video ...

IDEX Corporation (IEX) is scheduled to release third-quarter 2024 results on Oct. 29, after market close. The Zacks Consensus Estimate for earnings has remained steady in the past 60 days. The company has an impressive earnings surprise history, having outperformed the consensus estimate in each of the preceding four quarters, the average surprise being 5.9%. The consensus estimate for revenues is pegged at $791 million, indicating a decline of 0.3% from the prior-year quarter's figure. The consensus estima ...

文章核心观点 - 公司完成了一次私募配股,共募集资金7000万挪威克朗 [1] - 公司将发行第二批配股,并将在挪威金融监管局批准后发布招股说明书 [1] - 公司的股本将增加至12.08亿挪威克朗,分为8.05亿股,每股面值0.15挪威克朗 [1] 公司概况 - IDEX Biometrics是一家指纹生物识别技术领导者,为支付、门禁和数字身份认证提供解决方案 [2] - 公司的生物识别解决方案基于专利和专有的传感器技术、集成电路设计和软件 [2] - 公司与主要的卡制造商和技术公司合作,将解决方案推向市场 [2] 公告信息 - 该公告由公司财务副总裁Erling Svela于2024年10月14日发布 [3] - 公告内容符合挪威证券交易法的披露要求 [3]

IDEX Biometrics ASA held an extraordinary general meeting on 9 October 2024. 112.2 million shares or 25.47% of the share capital was represented at the meeting. All proposals on the agenda were adopted in accordance with the proposals of the Company's board of directors, including the approval of Tranche 2 of the private placement, the subsequent offering and the warrants issuance, all as announced on 17 September 2024. For further information contact: Marianne Bøe, Head of Investor Relations E-mail: ir@ide ...

Reference is made to the notice on 25 September 2024 regarding issue of Tranche 1 shares of the private placement completed on 16 September 2024. The private placement consisted of two tranches, with total gross proceeds amounting to NOK 70 million. The share capital increase related to the Tranche 1 shares has been registered and the shares will be delivered soonest. The Tranche 1 shares will be delivered on a separate and non-tradable ISIN, pending publication by the Company of a prospectus approved by th ...

Reference is made to the announcement by IDEX Biometrics ASA (the "Company") on 17 September 2024 regarding the private placement of shares with gross proceeds of NOK 70 million (the "Private Placement"). The Company retained Arctic Securities AS as sole manager and bookrunner for the Private Placement (the "Manager"). The Private Placement is divided into two tranches. 101,624,966 shares were allocated in the first tranche ("Tranche 1" and the "Tranche 1 Offer Shares") and 365,041,700 Offer Shares were all ...